Many drugs exert anti-cancer, anti-apoptosis, anti-oxidation, and anti-inflammatory effects by regulating the expression and activity of NRF2 (Copple et al., 2010; Sun et al., 2015). The gene discussed is NFE2L2; the disease is cancer.